On the winning side of Wall Street were Novo Nordisk’s U.S.-listed shares, which jumped 8.6%. The Danish company reported results from a clinical trial of a treatment for people who are overweight or ...
Market participants better buckle up, for WallStreet is in store for an incredibly busy week. Monetary policy is back in the spotlight, with the Federal Reserve's first interest rate decision ...